Quick Answer
Profound Medical Corp. reported Diluted EPS of $1.41 per share for fiscal year 2025.
Profound Medical Corp. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.41 | +25.9% |
| 2024 | $1.12 | -16.4% |
| 2023 | $1.34 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.26 | -31.6% | -50.0% |
| June 30, 2025 | $0.52 | +85.7% | +44.4% |
| March 31, 2025 | $0.36 | +33.3% | -5.3% |
| September 30, 2024 | $0.38 | — | +35.7% |
| June 30, 2024 | $0.28 | — | +3.7% |
| March 31, 2024 | $0.27 | — | — |
- Profound Medical Corp. showed an increase of +25.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Profound Medical Corp.’s diluted eps has grown by 5.2% (from $1.34 per share to $1.41 per share).
- The most recent figure is from Profound Medical Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: